FLGT  valuation analysis

Basics
Name: Fulgent Genetics, Inc
Description: Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. (more)
Industry: Diagnostics & Research
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 06, 2021
Market cap: $2.22B (1020th)
Sales(TTM): $773.39M (1081st)
Earnings(TTM): $416.96M (439th)

Value
FFER: 0.92 (why)
Actual price: $76.63
FFEThis is Fulgent Genetics, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $83.32
Quantile: FLGT is priced correctly given its fundamentals.
Prices as of EOD 2021-07-15
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Fulgent Genetics, Inc's earnings increased from -$459,000 to $416.96M in the last year.
  • Fulgent Genetics, Inc's sales grew by 2115.3% ($34.91M to $773.39M) over one year against a market average growth of 20.1%.
  • Fulgent Genetics, Inc's operating income increased from -$519,000 to $558.99M in the last year.
Earnings / MarketCap
Fulgent Genetics, Inc
"Diagnostics & Research" industry
Sales / MarketCap
Fulgent Genetics, Inc
"Diagnostics & Research" industry
Book / MarketCap
Fulgent Genetics, Inc
"Diagnostics & Research" industry
Equity / Assets
Fulgent Genetics, Inc
"Diagnostics & Research" industry